sj-docx-1-tau-10.1177_17562872211043341 – Supplemental material for The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide

Serrano Domingo, Juan José; Alonso Gordoa, Teresa; Lorca Álvaro, Javier; Molina-Cerrillo, Javier; Barquín García, Arantzazu; Martínez Sáez, Olga; Burgos Revilla, Javier; Carrato, Alfredo; Álvarez Rodríguez, Sara

doi:10.25384/SAGE.16640534.v1

sj-docx-1-tau-10.1177_17562872211043341.docx (64.51 kB)

sj-docx-1-tau-10.1177_17562872211043341 – Supplemental material for The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide

journal contribution

posted on 2021-09-19, 00:06 authored by Juan José Serrano Domingo, Teresa Alonso Gordoa, Javier Lorca Álvaro, Javier Molina-Cerrillo, Arantzazu Barquín García, Olga Martínez Sáez, Javier Burgos Revilla, Alfredo Carrato, Sara Álvarez Rodríguez

Supplemental material, sj-docx-1-tau-10.1177_17562872211043341 for The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide by Juan José Serrano Domingo, Teresa Alonso Gordoa, Javier Lorca Álvaro, Javier Molina-Cerrillo, Arantzazu Barquín García, Olga Martínez Sáez, Javier Burgos Revilla, Alfredo Carrato and Sara Álvarez Rodríguez in Therapeutic Advances in Urology